A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells
David H. Quach(Houston Methodist), Cliona M. Rooney(Texas Children's Hospital)
Cited by 26
Related Papers
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
|Blood|2014|738
Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease
|The Journal of Experimental Medicine|2004|390
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
|Cell Reports|2016|283
CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity
|Blood|2021|211
A Sympathetic Neuron Autonomous Role for Egr3-Mediated Gene Regulation in Dendrite Morphogenesis and Target Tissue Innervation
|Journal of Neuroscience|2013|40